RxDoctor Payments Data

Edward Dohring, MD

Orthopaedic Surgery of the Spine · Scottsdale, AZNPI 1619962776

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.6%), grants and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Orthofix Medical, Inc. at 47.7% of the total. Reporting peaked in 2023 at $8,956 and has fallen 81.0% since, to $1,705 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in AZ, where the typical reported total is $49,864.

$16,451in general payments, 2019–2025

Across 63 payments — averaging $261.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$8K
  • Medtronic$7K
  • Carl Zeiss Meditec USA, Inc.$713
  • Intrinsic Therapeutics$201
  • Seaspine Orthopedics Corporation$172
  • Globus Medical$159
  • plus $257 from 2 others

What the payments were for

  • Consulting fees$7,00043%
  • Grants$3,30520%
  • Travel & lodging$2,99518%
  • Food & beverage$3,15019%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,451 in reported general payments places this provider in the 35th percentile of 64 orthopaedic surgery of the spine providers in Arizona.

See all orthopaedic surgery of the spine providers in Arizona

Medicare billing

Part B allowed, 2024
$114,860
Medicare patients
106
Services billed
415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin22$317
Pregabalin17$271
Cyclobenzaprine Hcl18$221
Meloxicam25$95
Methylprednisolone12$46

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →